Developer docs
API playgroundTry for free, no card

Search company profiles

WellSync

Full company profile

uuid0006xmb

Namestring
WellSync
Legal namestring
Click to Fill, Inc.
Websiteurl
wellsync.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

WellSync (legally Click to Fill, Inc.) is a private, Tampa-based digital healthcare aggregator founded in 2022 that sells white-labeled, API-driven virtual care infrastructure to pharmacies, retailers, direct-to-consumer companies, large employers, labs, and healthcare innovators. The platform enables partners to deploy branded telehealth experiences — including synchronous video consultations and asynchronous questionnaire-based care reviewed by clinicians in under two minutes — without building underlying technology themselves. Supporting capabilities span remote patient monitoring, lab testing integration, branded pharmacy discount programs, and integrated fulfillment through URAC-accredited partner pharmacies.

The company's core technology layer is complemented by a consumer-facing brand portfolio including InstaCare (acute care at $25 per visit), the WellSync Weight Loss GLP-1 program ($229-$1,399/month), Whole Health Rx (powered for The Vitamin Shoppe), and In-Store Virtual Clinics (QR-code kiosks deployed at Publix). In July 2025, WellSync launched BoomRx as a national pharmaceutical technology subsidiary, which has scaled to serve more than 4,500 clinics across all 50 states and process over 40,000 prescription orders per month at a 20% month-over-month growth rate and 85% clinic return rate, reaching a $70M+ annualized run rate by June 2026.

The business operates on a cash-pay model with revenue generated from per-visit consultation fees, recurring GLP-1 subscriptions, B2B platform licensing to enterprise partners, and pharmacy fulfillment transaction fees. Distribution combines direct enterprise sales (Publix, Meijer, The Vitamin Shoppe, GenoPalate, Marius Pharmaceuticals) with self-serve D2C channels and embedded white-label deployment into partner websites and apps. The company is founder-led by CEO Clint House and President/CMO/Founder Edward O'Bryan, MD, with 11-50 employees and no disclosed institutional funding.

Short descriptiontext

WellSync is a private digital healthcare aggregator providing white-labeled, API-driven virtual care platforms to pharmacies, retailers, and direct-to-consumer companies. Its BoomRx subsidiary serves 4,500+ clinics across all 50 states, processing 40,000+ prescriptions monthly.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGainesville, United States
HQ citystring
Gainesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
virtual care platform, white-label telehealth, pharmacy fulfillment services, telemedicine solutions, GLP-1 weight loss programs
Industry4 codes
PRIMARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAH
Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALALAF
Telepharmacy & Prescription Fulfillment Marketplaces
Healthcare & Life Sciences/Telehealth Platforms/Telehealth Marketplace & Referral Platforms
NAICS code3 codes
  • Other Ambulatory Health Care Services6219
  • Pharmacies and Drug Retailers45611
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code3 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Digital Health / Virtual Care Platform
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Per-Visit Consultation Fees
TypeTransaction Fee
Description

WellSync charges per-visit fees for telehealth consultations ranging from $25-$99 depending on service type and complexity, including general consultations, HRT, and specialty services.

wellsync.com
2Subscription/Recurring Programs
TypeSubscription Recurring
Description

GLP-1 weight loss programs and ongoing medication management services generate recurring subscription revenue through monthly or ongoing treatment programs.

wellsync.com
3Platform Licensing (B2B)
TypeLicensing Royalties
Description

White-label platform deployment to enterprise partners generates licensing and service fees from pharmacies, retailers, D2C companies, and healthcare organizations seeking to embed virtual care capabilities.

wellsync.com
4Pharmacy Fulfillment
TypeTransaction Fee
Description

Mail order and retail pharmacy fulfillment services including prescription processing and medication delivery, with BoomRx subsidiary processing over 40,000 orders per month.

wellsync.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details6 tiers
1InstaCare General Consultations - $25 per visit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

General health consultations including allergies, flu, sinus infections, UTIs, and other common conditions. Starting at $25 per visit with no insurance required.

care.wellsync.com
2Meijer Virtual Care Partnership - $29.99 per visit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Virtual healthcare service through Meijer partnership offering treatment for cold, flu, allergies, and hair loss. Requires no insurance, accessible via Meijer's website, pharmacy app, or text 'Care' to 75049.

care.wellsync.com
3Hormone Replacement Therapy (HRT) - $99 per 30-day cycle
ModelUnit PricingBilling cadencePay-as-you-go
Notes

HRT services including Bi-est Cream, Estradiol Cream, and Estradiol Pills at $99 each per 30-day supply.

hub.wellsync.com
4Compound GLP-1 Medications - $229-$329 monthly
ModelSubscriptionBilling cadenceMonthly
Notes

Compound Semaglutide (Injection or ODT) at $229/month; Compound Tirzepatide (Injection or ODT) at $329/month. Includes 15% average body weight reduction potential.

weightloss.wellsync.com
5Brand-name GLP-1 Medications - $1,299-$1,399 monthly
ModelSubscriptionBilling cadenceMonthly
Notes

Ozempic (Semaglutide Injection) at $1,299/month; Mounjaro (Tirzepatide Injection) at $1,399/month.

weightloss.wellsync.com
6In-store Virtual Clinic - $25 per visit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

In-store virtual clinics at retail locations (Publix) enabling medical consultations via QR code scanning for a flat $25 fee.

weightloss.wellsync.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 3 records shown
1BoomRx
Description

National pharmaceutical technology platform providing prescription management services, processing over 40,000 orders per month across 4,500+ clinics in all 50 states.

aijourn.com
+2 more records
Core offering1 text field

WellSync operates as an agnostic digital healthcare aggregator providing a white-labeled, API-driven virtual care platform that enables pharmacies, retailers, D2C companies, employers, and labs to deploy synchronous and asynchronous telemedicine, prescription management, pharmacy fulfillment, lab testing, and remote patient monitoring under their own brands. The company sells the platform via B2B licensing to enterprise partners and additionally offers direct-to-consumer telehealth services including InstaCare acute consultations starting at $25/visit, GLP-1 weight loss subscriptions ($229-$1,399/month), HRT, and branded pharmacy discount cards.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • BoomRx subsidiary exceeded $70M annualized run rate, serving 4,500+ clinics with 85% clinic return rate and 20% month-over-month growth
+3 more records
Product overview1 text field

WellSync offers a modular virtual-first healthcare platform architecture comprising a white-labeled B2B core platform with multiple patient-facing interfaces and specialized product lines. The core WellSync Virtual-First Care Platform serves as the foundational infrastructure for B2B partners (pharmacies, retailers, DTC companies, employers), while the Care Hub (hub.wellsync.com) and InstaCare (care.wellsync.com) provide consumer-facing access points. Specialized verticals include BoomRx (pharmaceutical technology subsidiary launched July 2025, exceeding $70M annualized run rate), WellSync Weight Loss (GLP-1 program at weightloss.wellsync.com), and In-Store Virtual Clinics (retail QR-code kiosks). Supporting modules include Remote Patient Monitoring, Lab Testing & Diagnostics, Mail Order and Retail Pharmacy Fulfillment, Branded Pharmacy Discount Programs, Nutritional Supplementation, and the Rx Savings Card. The platform operates an asynchronous care model using questionnaire-based assessments reviewed by clinicians, with pricing from $25/visit for standard care to $1,399/month for weight loss medications.

Product and service8 records
1WellSync Virtual-First Care Platform
CategoryVirtual Care Platform / SaaS
Description

White-labeled, end-to-end virtual-first healthcare platform that enables pharmacies, direct-to-consumer companies, labs, large employers, and healthcare innovators to deliver scalable virtual care experiences including telemedicine, pharmacy fulfillment, RPM, and lab integration.

2BoomRx
CategoryPharmaceutical Technology Platform
Description

National pharmaceutical technology platform and WellSync subsidiary offering prescription-management services to clinics across all 50 states.

3InstaCare
CategoryDirect-to-Consumer Telehealth Service
Description

Acute care telehealth service offering treatment for common conditions (allergies, sinus infections, flu, headaches) at $25 per visit using asynchronous questionnaire-based assessments reviewed by clinicians within one hour.

4WellSync Weight Loss (GLP-1 Program)
CategoryWeight Management Subscription Service
Description

Weight loss subscription program offering GLP-1 medications including compounded semaglutide and tirzepatide (oral and injection) plus brand-name Ozempic and Mounjaro, with pricing from $229-$1,399/month.

5In-Store Virtual Clinics
CategoryRetail Virtual Care Service
Description

Retail-integrated virtual care kiosks deployed via QR code at partner retail locations enabling on-site medical consultations, diagnosis, prescriptions, and health products for $25 per visit.

6WellSync Rx Savings Card
CategoryPharmacy Discount Program
Description

Free prescription discount card offering savings up to 80% on medications across participating pharmacies.

7Care Hub
CategoryDirect-to-Consumer Telehealth Service
Description

Patient-facing care platform offering asynchronous care for 35+ conditions across General Health, Men's Health, Women's Health, Sexual Health, Skin and Hair, and Medication Refills starting at $25 per visit.

8Hormone Replacement Therapy (HRT) Program
CategoryDirect-to-Consumer Telehealth Service
Description

Virtual HRT program offering Bi-est Cream, Estradiol Cream, and Estradiol Pills at $99 per 30-day supply via asynchronous consultations.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-19
Description

Meijer partnership launched January 2026 offering virtual healthcare services to Meijer customers across the Midwest. Service costs $29.99/visit, requires no insurance, provides treatment for cold, flu, allergies, and hair loss through Meijer's website, pharmacy app, or text 'Care' to 75049. Partnership aims to remove healthcare access barriers for customers with busy schedules or transportation challenges.

2GenoPalate
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-09-09
Description

Partnership integrating WellSync's clinical care and GLP-1 prescription access with GenoPalate's personalized nutrition platform. GenoPalate's platform combines DNA, lifestyle, diet, and blood biomarkers with expert coaching for weight management, menopause, and longevity programs.

finance.yahoo.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-09-09
Description

WellSync collaborated with Marius Pharmaceuticals to offer KYZATREX (testosterone undecanoate) oral TRT on WellSync's virtual care platform. WellSync handles the complete patient journey from lab services pre-qualifying patients to virtual consultations, personalized treatment plans, and medication fulfillment shipped via URAC-accredited partner pharmacy.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-08-08
Description

WellSync launched in-store virtual clinics at Publix locations enabling customers to access medical consultations via QR code scanning for $25/visit. Deployed across Publix's network of over 1,300 stores in the Southeast United States, offering diagnosis, prescriptions, and health products on-site.

5The Vitamin Shoppe
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-05-01
Description

The Vitamin Shoppe launched Whole Health Rx, a virtual care platform powered by WellSync focusing on weight-management solutions. Partnership expanded in September 2024 to include testosterone replacement therapy (KYZATREX) within the Whole Health Rx telehealth platform.

hub.wellsync.com
Strategic tierCoreTypeOthers
Description

BoomRx is WellSync's national pharmaceutical technology platform subsidiary that has exceeded $70M annualized run rate since launching July 2025. Platform serves 4,500+ clinics across all 50 states, processing 40,000+ orders/month with 20% MoM growth and 85% clinic return rate.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pharmacy fulfillment and telehealth infrastructure provider powering DTC health brands — operates the same B2B white-label layer that BoomRx delivers within WellSync's stack.

TypeBroad incumbent
Description

Amazon's consumer virtual care and primary care service combining on-demand telehealth with in-person clinics and pharmacy — a well-capitalized incumbent competing for the same cash-pay and employer-sponsored segments.

TypeDirect peer
Description

Public DTC telehealth company offering prescription-based care across men's health, women's health, weight loss (GLP-1s), and acute conditions on a cash-pay model — the most direct competitor to WellSync's condition-specific Rx and white-label platform thesis.

TypeDirect peer
Description

Multi-brand virtual care company (Keeps, Nurx, Cove, etc.) operating condition-specific DTC clinics with cash-pay and pharmacy components — closely comparable to WellSync's condition-by-condition Rx approach.

5LillyDirect
TypeBroad incumbent
Description

Eli Lilly's direct-to-patient platform offering branded Zepbound and other medications with telehealth and pharmacy integration — a pharma-sponsored distribution channel that competes with WellSync's GLP-1 subscription business.

TypeBroad incumbent
Description

Largest publicly traded telehealth incumbent offering broad virtual care across primary care, chronic condition management, and mental health — represents the enterprise/insurance-integrated alternative to WellSync's cash-pay, white-label model.

7Ro
TypeDirect peer
Description

DTC telehealth platform offering condition-specific prescription programs (weight loss, men's health, fertility, dermatology) with pharmacy fulfillment infrastructure — overlaps directly with WellSync's consumer cash-pay clinics and Rx management stack.

8K Health
TypeDirect peer
Description

AI-driven virtual primary care platform offering condition-specific consultations and prescription treatments, increasingly including weight management — comparable to WellSync's asynchronous, low-friction care model.

TypeDirect peer
Description

Cash-pay telehealth marketplace offering $25+ visits across acute and chronic conditions, with prescription fulfillment — overlaps directly with WellSync's InstaCare price point and consumer funnel.

TypeEmerging player
Description

Specialty telehealth platform focused on women's midlife and hormonal health, including HRT — directly overlaps with WellSync's HRT and women's health condition modules.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WellSync

Digital Health / Virtual Care Platformwellsync.com

WellSync is a private digital healthcare aggregator providing white-labeled, API-driven virtual care platforms to pharmacies, retailers, and direct-to-consumer companies. Its BoomRx subsidiary serves 4,500+ clinics across all 50 states, processing 40,000+ prescriptions monthly.

What WellSync does

WellSync (legally Click to Fill, Inc.) is a private, Tampa-based digital healthcare aggregator founded in 2022 that sells white-labeled, API-driven virtual care infrastructure to pharmacies, retailers, direct-to-consumer companies, large employers, labs, and healthcare innovators. The platform enables partners to deploy branded telehealth experiences — including synchronous video consultations and asynchronous questionnaire-based care reviewed by clinicians in under two minutes — without building underlying technology themselves. Supporting capabilities span remote patient monitoring, lab testing integration, branded pharmacy discount programs, and integrated fulfillment through URAC-accredited partner pharmacies.

The company's core technology layer is complemented by a consumer-facing brand portfolio including InstaCare (acute care at $25 per visit), the WellSync Weight Loss GLP-1 program ($229-$1,399/month), Whole Health Rx (powered for The Vitamin Shoppe), and In-Store Virtual Clinics (QR-code kiosks deployed at Publix). In July 2025, WellSync launched BoomRx as a national pharmaceutical technology subsidiary, which has scaled to serve more than 4,500 clinics across all 50 states and process over 40,000 prescription orders per month at a 20% month-over-month growth rate and 85% clinic return rate, reaching a $70M+ annualized run rate by June 2026.

The business operates on a cash-pay model with revenue generated from per-visit consultation fees, recurring GLP-1 subscriptions, B2B platform licensing to enterprise partners, and pharmacy fulfillment transaction fees. Distribution combines direct enterprise sales (Publix, Meijer, The Vitamin Shoppe, GenoPalate, Marius Pharmaceuticals) with self-serve D2C channels and embedded white-label deployment into partner websites and apps. The company is founder-led by CEO Clint House and President/CMO/Founder Edward O'Bryan, MD, with 11-50 employees and no disclosed institutional funding.

WellSync firmographics

Firmographics
Name
WellSync
Legal name
Click to Fill, Inc.
Website
https://wellsync.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
WellSync is a private digital healthcare aggregator providing white-labeled, API-driven virtual care platforms to pharmacies, retailers, and direct-to-consumer companies. Its BoomRx subsidiary serves 4,500+ clinics across all 50 states, processing 40,000+ prescriptions monthly.
Ownership category
akta.pro rank

WellSync industry classification

Industry
Product category
Digital Health / Virtual Care Platform
NAICS
Other Ambulatory Health Care Services (6219), Pharmacies and Drug Retailers (45611), Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Retail-Drug Stores And Proprietary Stores (5912)
akta.pro industry
PRIMARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLALAIAA
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAH
Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALALAF
Telepharmacy & Prescription Fulfillment Marketplaces
Healthcare & Life Sciences/Telehealth Platforms/Telehealth Marketplace & Referral Platforms

Keywords

  • Virtual care platform
  • White-label telehealth
  • Pharmacy fulfillment services
  • Telemedicine solutions
  • GLP-1 weight loss programs

Where WellSync is headquartered

Location

Headquarters

HQ city
Gainesville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

WellSync business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Per-Visit Consultation Fees: WellSync charges per-visit fees for telehealth consultations ranging from $25-$99 depending on service type and complexity, including general consultations, HRT, and specialty services.
  2. Subscription/Recurring Programs: GLP-1 weight loss programs and ongoing medication management services generate recurring subscription revenue through monthly or ongoing treatment programs.
  3. Platform Licensing (B2B): White-label platform deployment to enterprise partners generates licensing and service fees from pharmacies, retailers, D2C companies, and healthcare organizations seeking to embed virtual care capabilities.
  4. Pharmacy Fulfillment: Mail order and retail pharmacy fulfillment services including prescription processing and medication delivery, with BoomRx subsidiary processing over 40,000 orders per month.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goInstaCare General Consultations - $25 per visit
Unit PricingPay-as-you-goMeijer Virtual Care Partnership - $29.99 per visit
Unit PricingPay-as-you-goHormone Replacement Therapy (HRT) - $99 per 30-day cycle
SubscriptionMonthlyCompound GLP-1 Medications - $229-$329 monthly
SubscriptionMonthlyBrand-name GLP-1 Medications - $1,299-$1,399 monthly
Unit PricingPay-as-you-goIn-store Virtual Clinic - $25 per visit

Go-to-market motion3 records

Distribution channels8 records

Marketing channels8 records

WellSync product offering

Product offering

Core offering

WellSync operates as an agnostic digital healthcare aggregator providing a white-labeled, API-driven virtual care platform that enables pharmacies, retailers, D2C companies, employers, and labs to deploy synchronous and asynchronous telemedicine, prescription management, pharmacy fulfillment, lab testing, and remote patient monitoring under their own brands. The company sells the platform via B2B licensing to enterprise partners and additionally offers direct-to-consumer telehealth services including InstaCare acute consultations starting at $25/visit, GLP-1 weight loss subscriptions ($229-$1,399/month), HRT, and branded pharmacy discount cards.

Product overview

WellSync offers a modular virtual-first healthcare platform architecture comprising a white-labeled B2B core platform with multiple patient-facing interfaces and specialized product lines. The core WellSync Virtual-First Care Platform serves as the foundational infrastructure for B2B partners (pharmacies, retailers, DTC companies, employers), while the Care Hub (hub.wellsync.com) and InstaCare (care.wellsync.com) provide consumer-facing access points. Specialized verticals include BoomRx (pharmaceutical technology subsidiary launched July 2025, exceeding $70M annualized run rate), WellSync Weight Loss (GLP-1 program at weightloss.wellsync.com), and In-Store Virtual Clinics (retail QR-code kiosks). Supporting modules include Remote Patient Monitoring, Lab Testing & Diagnostics, Mail Order and Retail Pharmacy Fulfillment, Branded Pharmacy Discount Programs, Nutritional Supplementation, and the Rx Savings Card. The platform operates an asynchronous care model using questionnaire-based assessments reviewed by clinicians, with pricing from $25/visit for standard care to $1,399/month for weight loss medications.

Differentiator

Problem solved

Functional benefit

Brands

  • BoomRx: National pharmaceutical technology platform providing prescription management services, processing over 40,000 orders per month across 4,500+ clinics in all 50 states.
  • WellSync GLP1
  • Whole Health Rx

Products and services

  • WellSync Virtual-First Care Platform White-labeled, end-to-end virtual-first healthcare platform that enables pharmacies, direct-to-consumer companies, labs, large employers, and healthcare innovators to deliver scalable virtual care experiences including telemedicine, pharmacy fulfillment, RPM, and lab integration.
  • BoomRx National pharmaceutical technology platform and WellSync subsidiary offering prescription-management services to clinics across all 50 states.
  • InstaCare Acute care telehealth service offering treatment for common conditions (allergies, sinus infections, flu, headaches) at $25 per visit using asynchronous questionnaire-based assessments reviewed by clinicians within one hour.
  • WellSync Weight Loss (GLP-1 Program) Weight loss subscription program offering GLP-1 medications including compounded semaglutide and tirzepatide (oral and injection) plus brand-name Ozempic and Mounjaro, with pricing from $229-$1,399/month.
  • In-Store Virtual Clinics Retail-integrated virtual care kiosks deployed via QR code at partner retail locations enabling on-site medical consultations, diagnosis, prescriptions, and health products for $25 per visit.
  • WellSync Rx Savings Card Free prescription discount card offering savings up to 80% on medications across participating pharmacies.
  • Care Hub Patient-facing care platform offering asynchronous care for 35+ conditions across General Health, Men's Health, Women's Health, Sexual Health, Skin and Hair, and Medication Refills starting at $25 per visit.
  • Hormone Replacement Therapy (HRT) Program Virtual HRT program offering Bi-est Cream, Estradiol Cream, and Estradiol Pills at $99 per 30-day supply via asynchronous consultations.

Quantifiable outcome

  • BoomRx subsidiary exceeded $70M annualized run rate, serving 4,500+ clinics with 85% clinic return rate and 20% month-over-month growth
  • +3 more outcomes

Companies that use WellSync

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

WellSync technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature6 records

WellSync partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and strategic.

  • MeijercoreChannel Partner/ Reseller/ Distributor · 19 January 2026Meijer partnership launched January 2026 offering virtual healthcare services to Meijer customers across the Midwest. Service costs $29.99/visit, requires no insurance, provides treatment for cold, flu, allergies, and hair loss through Meijer's website, pharmacy app, or text 'Care' to 75049. Partnership aims to remove healthcare access barriers for customers with busy schedules or transportation challenges.
  • GenoPalatestrategicStrategic or Co-development Partner · 9 September 2025Partnership integrating WellSync's clinical care and GLP-1 prescription access with GenoPalate's personalized nutrition platform. GenoPalate's platform combines DNA, lifestyle, diet, and blood biomarkers with expert coaching for weight management, menopause, and longevity programs.
  • Marius PharmaceuticalsstrategicStrategic or Co-development Partner · 9 September 2024WellSync collaborated with Marius Pharmaceuticals to offer KYZATREX (testosterone undecanoate) oral TRT on WellSync's virtual care platform. WellSync handles the complete patient journey from lab services pre-qualifying patients to virtual consultations, personalized treatment plans, and medication fulfillment shipped via URAC-accredited partner pharmacy.
  • PublixcoreChannel Partner/ Reseller/ Distributor · 8 August 2024WellSync launched in-store virtual clinics at Publix locations enabling customers to access medical consultations via QR code scanning for $25/visit. Deployed across Publix's network of over 1,300 stores in the Southeast United States, offering diagnosis, prescriptions, and health products on-site.
  • The Vitamin ShoppecoreChannel Partner/ Reseller/ Distributor · 1 May 2024The Vitamin Shoppe launched Whole Health Rx, a virtual care platform powered by WellSync focusing on weight-management solutions. Partnership expanded in September 2024 to include testosterone replacement therapy (KYZATREX) within the Whole Health Rx telehealth platform.
  • BoomRxcoreOthersBoomRx is WellSync's national pharmaceutical technology platform subsidiary that has exceeded $70M annualized run rate since launching July 2025. Platform serves 4,500+ clinics across all 50 states, processing 40,000+ orders/month with 20% MoM growth and 85% clinic return rate.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

WellSync competitors and assessment

Company assessment

Direct peers

  • Truepill: Pharmacy fulfillment and telehealth infrastructure provider powering DTC health brands — operates the same B2B white-label layer that BoomRx delivers within WellSync's stack.
  • Hims & Hers Health: Public DTC telehealth company offering prescription-based care across men's health, women's health, weight loss (GLP-1s), and acute conditions on a cash-pay model — the most direct competitor to WellSync's condition-specific Rx and white-label platform thesis.
  • Thirty Madison: Multi-brand virtual care company (Keeps, Nurx, Cove, etc.) operating condition-specific DTC clinics with cash-pay and pharmacy components — closely comparable to WellSync's condition-by-condition Rx approach.
  • Ro: DTC telehealth platform offering condition-specific prescription programs (weight loss, men's health, fertility, dermatology) with pharmacy fulfillment infrastructure — overlaps directly with WellSync's consumer cash-pay clinics and Rx management stack.
  • K Health: AI-driven virtual primary care platform offering condition-specific consultations and prescription treatments, increasingly including weight management — comparable to WellSync's asynchronous, low-friction care model.
  • Sesame: Cash-pay telehealth marketplace offering $25+ visits across acute and chronic conditions, with prescription fulfillment — overlaps directly with WellSync's InstaCare price point and consumer funnel.

Broad incumbents

  • Amazon One Medical: Amazon's consumer virtual care and primary care service combining on-demand telehealth with in-person clinics and pharmacy — a well-capitalized incumbent competing for the same cash-pay and employer-sponsored segments.
  • LillyDirect: Eli Lilly's direct-to-patient platform offering branded Zepbound and other medications with telehealth and pharmacy integration — a pharma-sponsored distribution channel that competes with WellSync's GLP-1 subscription business.
  • Teladoc Health: Largest publicly traded telehealth incumbent offering broad virtual care across primary care, chronic condition management, and mental health — represents the enterprise/insurance-integrated alternative to WellSync's cash-pay, white-label model.

Emerging players

  • Midi Health: Specialty telehealth platform focused on women's midlife and hormonal health, including HRT — directly overlaps with WellSync's HRT and women's health condition modules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

WellSync social profiles

Digital presence

WellSync compliance and trust

Trust signal

Compliance4 records

WellSync financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WellSync leadership team

Management profile

Number of profiles

Profiles3 records

WellSync subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

WellSync funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WellSync M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WellSync

What does WellSync do?

WellSync operates as an agnostic digital healthcare aggregator providing a white-labeled, API-driven virtual care platform that enables pharmacies, retailers, D2C companies, employers, and labs to deploy synchronous and asynchronous telemedicine, prescription management, pharmacy fulfillment, lab testing, and remote patient monitoring under their own brands. The company sells the platform via B2B licensing to enterprise partners and additionally offers direct-to-consumer telehealth services including InstaCare acute consultations starting at $25/visit, GLP-1 weight loss subscriptions ($229-$1,399/month), HRT, and branded pharmacy discount cards.

Is WellSync a public or private company?

WellSync is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was WellSync founded?

WellSync was founded in 2022. It employs 11 to 50 people.

Where is WellSync based?

WellSync is headquartered in Gainesville, United States, in the North America region.

How does WellSync make money?

Four revenue lines are on record. Per-Visit Consultation Fees are the primary driver. The others are subscription/Recurring Programs, platform Licensing (B2B) and pharmacy Fulfillment.

Who are WellSync's main competitors?

Direct peers on record are Truepill, Hims & Hers Health, Thirty Madison, Ro, K Health and Sesame. Broad incumbents are Amazon One Medical, LillyDirect and Teladoc Health. Midi Health is listed as an emerging player.

Does WellSync have an API?

Yes. WellSync offers API-driven white-labeled healthcare technology that enables partners to integrate virtual care capabilities into their platforms. Features include synchronous and asynchronous telemedicine solutions, branded pharmacy discount programs, mail order pharmacy fulfillment, retail pharmacy integration, remote patient monitoring, lab testing integration, and provider network connectivity. Partners can deploy customizable, easy-to-use virtual care platforms that can be plugged into existing websites within days. The API supports connectivity for healthcare data exchange and patient care coordination.

What industry is WellSync in?

WellSync's product category is Digital Health / Virtual Care Platform. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription). Its NAICS code is 6219 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournWellSync Reports Strong BoomRx Momentum with More Than $70-Million Annualized Run RateWellSync announced that its subsidiary BoomRx, a national pharmaceutical technology platform, has exceeded a $70-million annualized run rate since launching in July 2025, marking a key milestone for the company's digital healthcare ecosystem. The BoomRx platform is now used by more than 4,500 clinics across all 50 states, processing over 40,000 orders per month with 20-percent month-over-month growth and an 85-percent clinic return rate. The company cited growing demand for integrated virtual-care infrastructure, with the global telehealth market projected to expand from approximately $219 billion in 2026 to over $1.2 trillion by 2034.PR NewswireWellSync Reports Strong BoomRx Momentum with More Than $70-Million Annualized Run RateWellSync announced that its subsidiary BoomRx has exceeded a $70-million annualized run rate since launching in July 2025, establishing the platform as a flagship solution within WellSync's digital healthcare ecosystem. The BoomRx prescription-management platform now serves more than 4,500 clinics across all 50 states, processing over 40,000 orders per month with 20-percent month-over-month growth and an 85-percent clinic return rate. The milestone reflects growing demand for integrated virtual-care infrastructure as the global telehealth market is projected to expand from $219 billion in 2026 to over $1.2 trillion by 2034.DBusiness MagazineMeijer and WellSync Partner on Virtual Health Care PlatformMeijer, a Grand Rapids-based retailer operating more than 500 supercenters and grocery stores across the Midwest, has announced a partnership with WellSync, a virtual-first health care platform, to offer virtual health care services to its customers. The service costs $29.99 per visit, requires no insurance, and provides treatment for common conditions including cold, flu, allergies, and hair loss through Meijer's website or pharmacy app. The companies state the partnership aims to remove barriers to healthcare access for customers facing busy schedules or transportation challenges.Progressive GrocerMeijer Launches $29.99 Virtual Health Care With WellSyncMeijer Inc., a Midwest grocery chain, has launched a virtual health care service in partnership with WellSync, a virtual-first health care platform, offering treatment for common conditions such as cold, flu, allergies, and hair loss. The service costs $29.99 per visit, requires no insurance, and is accessible through Meijer's website or pharmacy app, with visits conducted by board-certified health care professionals. The partnership aligns with Meijer's mission to expand health care accessibility and support community well-being.Supermarket NewsMeijer partners with WellSync to offer virtual health care visitsMeijer has partnered with virtual-first healthcare platform WellSync to offer customers access to online medical visits for common health conditions such as colds, flu, allergies, and hair loss. The service costs $29.99, requires no insurance, and is accessible through Meijer's website, pharmacy app, or text message. Meijer's chief merchandising and marketing officer Don Sanderson said the partnership aims to expand healthcare access for customers facing barriers such as limited time or transportation challenges.TmcnetWellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men's HealthWellSync and Marius Pharmaceuticals announced a collaboration to offer KYZATREX, an oral testosterone replacement therapy, through WellSync's virtual care platform. The partnership enables direct-to-patient delivery via a URAC-accredited pharmacy, aiming to expand access to men's health treatments.YahooWellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men's HealthWellSync and Marius Pharmaceuticals announced a collaboration to offer KYZATREX, an oral testosterone replacement therapy, through WellSync's virtual care platform. Orders are fulfilled and discreetly shipped via a URAC-accredited pharmacy. The partnership aims to expand access to men's health treatments.Business & FinancialWellsync And Marius Pharmaceuticals Collaborate To Offer FDA-Approved Oral Testosterone Replacement Therapy, Expanding Virtual Care For Men's HealthWellSync and Marius Pharmaceuticals announced a collaboration to offer KYZATREX, an oral testosterone replacement therapy, through WellSync's virtual care platform. The partnership enables direct-to-patient delivery via a URAC-accredited pharmacy, aiming to expand access to men's health treatments.MorningstarWellSync Expands Partnership with The Vitamin Shoppe® to Power Testosterone Replacement Therapy on Whole Health Rx Telehealth PlatformWellSync expanded its partnership with The Vitamin Shoppe by launching a testosterone replacement therapy program featuring KYZATREX capsules on the Whole Health Rx telehealth platform. The move builds on its Medical Weight Loss initiative and aims to improve access to care for men with testosterone deficiency.Business & FinancialWellsync Expands Partnership With The Vitamin Shoppe® To Power Testosterone Replacement Therapy On Whole Health Rx Telehealth PlatformWellSync expanded its partnership with The Vitamin Shoppe by adding a testosterone replacement therapy program featuring KYZATREX capsules to its Whole Health Rx telehealth platform. The move aims to improve access to care for men with testosterone deficiency, building on the company's land-and-expand model.